Related Experiment Video
Updated: May 7, 2026

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
Deep brain stimulation in dementia-related disorders
Sarah Hescham1, Lee Wei Lim, Ali Jahanshahi
1Department of Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands; European Graduate School of Neuroscience (Euron), Maastricht, The Netherlands.
Deep brain stimulation (DBS) shows promise for enhancing memory in Alzheimer's disease (AD) and other dementias. Further clinical trials are needed to confirm its potential as a disease-modifying therapy.
Area of Science:
- Neuroscience
- Neurology
- Medical Technology
Background:
- Memory loss is a primary symptom of dementia, notably Alzheimer's disease (AD).
- Current pharmacological treatments for AD offer limited efficacy and short-term benefits.
- Novel therapeutic approaches are crucial for managing cognitive decline in AD.
Purpose of the Study:
- To explore the potential of deep brain stimulation (DBS) as a novel therapy for memory impairment in dementia.
- To evaluate the efficacy of DBS in enhancing memory functions and potentially halting disease progression.
- To investigate the underlying mechanisms of DBS-induced memory enhancement.
Main Methods:
- Review of clinical and preclinical studies involving DBS.
- Targeted stimulation of brain regions including the fornix, entorhinal cortex, and nucleus basalis of Meynert.
- Analysis of outcomes related to memory enhancement and disease modification.
Main Results:
- DBS demonstrated potential in enhancing memory functions in both human patients and animal models.
- Observed effects suggest neurotransmitter release and neuroplasticity as potential mechanisms.
- Some studies indicate DBS might possess disease-modifying properties.
Conclusions:
- DBS is a promising experimental therapy for memory impairment associated with dementia and Alzheimer's disease.
- Emerging evidence suggests DBS could offer disease-modifying effects.
- Further clinical trials are essential to validate DBS efficacy and safety for AD treatment.
More Related Videos
08:25Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
Published on: May 19, 2016
12:04Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 6, 2011